Related Experiment Videos
Tumor rejection by disturbing tumor stroma cell interactions
The Journal of Experimental Medicine
|December 6, 2001
Summary
T cells regulate tumor-infiltrating macrophages (TIMs) during cancer therapy. Cyclophosphamide treatment alters TIMs to produce interferon-gamma, destroying tumor vasculature and aiding rejection.
Area of Science:
- Immunology
- Oncology
- Tumor Microenvironment
Background:
- Solid tumors feature a complex stroma with diverse cell types.
- Tumor-infiltrating macrophages (TIMs) play a crucial role in tumor progression and immune evasion.
Purpose of the Study:
- To investigate stroma cell interactions during cyclophosphamide (Cy)-induced tumor rejection.
- To elucidate the role of TIMs and T cells in tumor rejection dynamics.
Main Methods:
- Analysis of two tumor models treated with cyclophosphamide.
- Monitoring of cytokine production (IL-10, IFN-gamma) by TIMs.
- Assessment of T cell inactivation and tumor vasculature destruction.
Main Results:
- TIMs produced IL-10 in growing tumors; this required T cells.
- Post-Cy treatment, TIMs switched to IFN-gamma production, dependent on T cells.
- Tumor vasculature destruction occurred with IFN-gamma production, requiring host IFN-gamma receptor expression.
Conclusions:
- T cells are critical regulators of TIM function in tumor rejection.
- Disturbing the tumor stroma network, particularly TIM function, can induce tumor rejection.
- This study highlights a therapeutic strategy targeting tumor stroma interactions.